Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss
- 1 December 2016
- journal article
- Published by Elsevier in Human Pathology
- Vol. 58, 161-170
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Assessing Copy Number Alterations in Targeted, Amplicon-Based Next-Generation Sequencing DataThe Journal of Molecular Diagnostics, 2015
- Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinomaVirchows Archiv, 2014
- Unusual primary cerebral localization of a CIC–DUX4 translocation tumor of the Ewing sarcoma familyActa Neuropathologica, 2014
- Myogenic Enhancers Regulate Expression of the Facioscapulohumeral Muscular Dystrophy-Associated DUX4 GeneMolecular and Cellular Biology, 2014
- Round cell sarcomas beyond Ewing: emerging entitiesHistopathology, 2013
- Undifferentiated Small Round Cell Sarcoma With t(4;19)(q35;q13.1) CIC-DUX4 FusionAmerican Journal of Surgical Pathology, 2013
- High prevalence of CIC fusion with double‐homeobox (DUX4) transcription factors in EWSR1‐negative undifferentiated small blue round cell sarcomasGenes, Chromosomes and Cancer, 2011
- Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor typesHuman Mutation, 2011
- Copy Number Alterations and Methylation in Ewing's SarcomaSarcoma, 2011
- Diagnostic and Prognostic Sarcoma SignaturesMolecular Diagnosis & Therapy, 2008